Mortality Rate Lower With Arteriovenous Fistulas
Patients receiving hemodialysis with arteriovenous fistulas vs central venous catheters are less likely to die or be hospitalized.
Patients receiving hemodialysis with arteriovenous fistulas vs central venous catheters are less likely to die or be hospitalized.
In a small study of hemodialysis patients, the highest 3 quartiles of serum thyrotropin were associated with nearly triple the risks for worse endothelial function.
From 1999 to 2018, the proportion of living kidney donors classified as overweight or mildly obese increased, while the proportion of those considered moderately or morbidly obese has decreased, a study found.
Even a low HAS-BLED score of 0 was associated with high risk for bleeding in this population: 5.6 per 100 patient-years.
Nearly half of patients with autosomal dominant polycystic kidney disease receive at least 1 CT scan over 2 years, study finds.
Patients with CKD stage 3 or 4 and atrial fibrillation treated with apixaban vs warfarin have a 36% decreased risk of stroke or venous thromboembolism, a meta-analysis found.
In 3 studies, patiromer reduced serum potassium by 0.65 to 1.01 meq/L at 4 weeks.
In hemodialysis patients with high ferritin levels at baseline, the iron-based phosphate binder ferric citrate increased mean transferrin saturation from 23.6% to 36.1% at 90 days.
In a study, hypocalcemia and gastrointestinal adverse events were managed through etelcalcetide dose modification or discontinuation.
Fibroblast growth factor 23 levels above the median are independently associated with shorter 6-minute walk distance and lower peak oxygen consumption on exercise testing, study finds.